Tower Research Capital LLC (Trc) Lineage Cell Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,390 shares of LCTX stock, worth $6,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,390

Previous 31,177 60.26%

Holding current value

$6,690

Previous $31,000 64.52%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.8 - $1.12 $15,029 - $21,041	-18,787 Reduced 60.26%	12,390 $11,000
Q2 2024 Aug 13, 2024	BUY	$0.89 - $1.47 $26,882 - $44,401	30,205 Added 3107.51%	31,177 $31,000
Q1 2024 May 15, 2024	SELL	$0.86 - $1.48 $6,308 - $10,855	-7,335 Reduced 88.3%	972 $1,000
Q4 2023 Feb 13, 2024	SELL	$0.91 - $1.35 $1,847 - $2,740	-2,030 Reduced 19.64%	8,307 $9,000
Q3 2023 Nov 14, 2023	BUY	$1.16 - $1.53 $2,738 - $3,612	2,361 Added 29.6%	10,337 $12,000
Q2 2023 Aug 14, 2023	SELL	$1.26 - $1.53 $2,509 - $3,047	-1,992 Reduced 19.98%	7,976 $11,000
Q1 2023 May 09, 2023	SELL	$1.2 - $1.53 $1,651 - $2,105	-1,376 Reduced 12.13%	9,968 $15,000
Q4 2022 Feb 10, 2023	BUY	$1.02 - $1.5 $11,262 - $16,563	11,042 Added 3656.29%	11,344 $13,000
Q3 2022 Nov 10, 2022	BUY	$1.13 - $1.77 $112 - $177	100 Added 49.5%	302 $0
Q2 2022 Aug 15, 2022	SELL	$1.12 - $1.61 $8,611 - $12,379	-7,689 Reduced 97.44%	202 $0
Q1 2022 May 12, 2022	BUY	$1.21 - $2.48 $100 - $205	83 Added 1.06%	7,891 $12,000
Q4 2021 Feb 14, 2022	BUY	$1.84 - $2.68 $7,656 - $11,151	4,161 Added 114.09%	7,808 $19,000
Q3 2021 Nov 15, 2021	SELL	$2.26 - $2.86 $11,227 - $14,208	-4,968 Reduced 57.67%	3,647 $9,000
Q2 2021 Aug 16, 2021	BUY	$2.17 - $3.0 $18,260 - $25,245	8,415 Added 4207.5%	8,615 $25,000
Q1 2021 May 17, 2021	BUY	$1.77 - $3.1 $354 - $620	200 New	200 $0
Q4 2020 Feb 16, 2021	SELL	$0.95 - $1.83 $14,558 - $28,044	-15,325 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.75 - $1.09 $19,443 - $28,257	-25,924 Reduced 62.85%	15,325 $14,000
Q2 2020 Aug 13, 2020	BUY	$0.71 - $1.18 $29,286 - $48,673	41,249 New	41,249 $36,000

Others Institutions Holding LCTX

# of Institutions

120

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $91.7M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Lineage Cell Therapeutics, Inc. Transaction History